Skip to main content
Products
Our company
Knowledge
Investors
Contact
Global languages
Global
engelska
Sverige
svenska
Local languages
Japanese Home Page
Brazilian Portuguesse Home Page
Chinese Home Page
Italian Home Page
Spanish home page
Portuguese home page
French home page
German home page
Middle East & Africa homepage
Register
Logga in
Pressmeddelanden
Rapporter och presentationer
Nyckeltal
Analytiker & Konsensus
Aktieinformation
Finansiell kalender
Bolagsstyrning
Ledning
Styrelse och utskott
Årsstämmor
Global languages
Global
engelska
Sverige
svenska
Local languages
Japanese Home Page
Brazilian Portuguesse Home Page
Chinese Home Page
Italian Home Page
Spanish home page
Portuguese home page
French home page
German home page
Middle East & Africa homepage
Logga in
Register
Logga in
Products
Solutions
All laboratories
Small labs
Large labs
Connecting labs
Veterinary
Hardware
CellaVision® DC-1
CellaVision® DM1200
CellaVision® DM9600
DIFF-Line™ by CellaVision
RAL® SmearBox
RAL® StainBox
RAL® Stainer
Software & applications
CellaVision® Peripheral Blood Application
CellaVision® Advanced RBC Application
CellaVision® Body Fluid Application
CellaVision® CellAtlas
CellaVision® Remote Review Software
CellaVision® Server Software
CellaVision®VET
CellaVision® Proficiency Software
Proficiency Features
Proficiency Workflow
Proficiency Tutorials
Proficiency FAQ
Reagents
Quality Documents
Our company
About us
We are CellaVision
Why CellaVision
Customer cases
Where to buy
Our History
Sustainability
News and Events
Newsroom
Events
Career
Knowledge
Training
For Product Users
For Distribution Partners
Training Schedule
Education
CellaVision Global Test
Educational Webinars
Patient Cases and Cell challenges
Staining
For School Instructors
Gimmicks & Games
Investors
Pressmeddelanden
Rapporter och presentationer
Nyckeltal
Analytiker & Konsensus
Aktieinformation
Finansiell kalender
Bolagsstyrning
Ledning
Styrelse och utskott
Årsstämmor
Contact
Hem
Investerare
CellaVision kvartalsrapport Q3
2004-10-18
Regulatorisk
CellaVision kvartalsrapport Q3
Share
